HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A novel OCRL1 gene mutation in a Turkish child with Lowe syndrome.

Abstract
Oculocerebrorenal syndrome, also known as Lowe syndrome, is an X-linked recessive disorder that predominantly affects males and is characterized by growth and mental retardation, congenital cataract and renal Fanconi syndrome. OCRL1 is the gene responsible for Lowe syndrome and encodes an inositol polyphosphate-5-phosphatase. We present an 11-year-old boy with Lowe syndrome, who had a de novo frameshift mutation in exon 22 that resulted in amino acid substitution and premature codon termination at position 788. This is a new mutation involving the OCRL1 gene in a patient with Lowe syndrome of Turkish origin and expands the mutation spectrum in this disorder.
AuthorsAli Kanık, Belde Kasap-Demir, Rüya Ateşli, Kayı Eliaçık, Onder Yavaşcan, Mehmet Helvacı
JournalThe Turkish journal of pediatrics (Turk J Pediatr) 2013 Jan-Feb Vol. 55 Issue 1 Pg. 82-5 ISSN: 0041-4301 [Print] Turkey
PMID23692838 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Phosphoric Monoester Hydrolases
  • OCRL protein, human
Topics
  • Child
  • Frameshift Mutation
  • Humans
  • Male
  • Oculocerebrorenal Syndrome (diagnostic imaging, genetics)
  • Phosphoric Monoester Hydrolases (genetics)
  • Physical Examination
  • Radiography
  • Turkey

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: